NEWS

NEWS TYPE
RELEASE YEAR

EVENT

[Open Seminar] Harvey Lodish, Ph.D.

June 19, 2024

June 19, 2024

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar as follows:

Date & Time Wednesday, June 12, 2024, 16:00 -17:30
Venue  (Hybrid)  1F Lounge, Center for Integrated Medical Research, Shinanomachi Campus, Keio University and on zoom
Title New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History
Speaker Harvey F. Lodish, Ph.D.
Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology (USA)
Lead author, “Molecular Cell Biology”
Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard
Language English

Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.

More Bio2Q News

EVENT
2025.01.06

The 3rd Keio University WPI-Bio2Q International Symposium

The Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold the 3rd Keio University WPI-Bio2Q International S...

RESEARCH
2025.01.06

[Publication] Advantages of Fixing Spins in Quantum Annealing

Title Advantages of Fixing Spins in Quantum Annealing Authors Tomohiro Hattori [1]; Hirotaka Irie [2]; Tadashi Kadowaki [2],[3]; and ...

RESEARCH
2025.01.06

[Publication] Characterization of UGT8 as a monogalactosyl diacylglycerol syntha...

Title Characterization of UGT8 as a monogalactosyl diacylglycerol synthase in mammals  Authors Yohsuke Ohba [1],[2]; Mizuki Motohashi...

ANNOUNCEMENT
2024.12.13

Five WPI-Bio2Q Researchers Named as “Highly Cited Researchers 2024”

Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) is proud to announce that five of our researchers were selected...

RESEARCH
2024.12.12

[Publication] The impact of retrotransposons on zygotic genome activation and th...

Title The impact of retrotransposons on zygotic genome activation and the chromatin landscape of early embryos Authors Therese Solber...